Show Notes
Further evidence for the use of the EarlyCDT Lung blood test in lung cancer screening
Dr Adam M Hill, CEO of Oncimmune, said: "Following last week's announcement of the publication of the ECLS trial in the European Respiratory Journal, we are delighted to see these additional abstracts presented online.
"Beyond proving the ability of the EarlyCDT Lung blood test to detect cancer earlier in a screening population, it is also important to assess the negative impacts of using the test in the population, and the costs of implementing the diagnostic. These findings will no doubt assist our ongoing commercial discussions with health authorities in the UK and in other territories, and we look forward to the peer reviewed publications in due course."
Listen On
Also Listen
-
Altona Rare Earths PLC (LON:REE) Dr Cedric Simonet spoke with Share Talk
Share Talk interviews Cédric Simonet, CEO of Altona Rare Earths (LON: REE), to d -
Zak Mir talking to Eddie Wyvill, head of Corporate Development – Amaroq Minerals Ltd.
Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine dev -
Zak Mir talking with Nick Tulloch, Chief Executive Officer of Mendell Helium
Zak Mir interviewed Mendell Helium CEO Nick Tulloch regarding M3Helium's new far -
ECR Minerals (AIM:ECR) Chairman Nick Tulloch, MD Mike Whitlow, Technical Consultant Mike Parker and Director Andrew Scott
ECR Minerals, a gold exploration company with assets in Australia, is making sig